To investigate the molecular mechanism for this epigenetic transition, Jacobsen and colleagues [1,11] performed EMS mutagenesis in a non-revertible, clk-st background, screening for progeny with a wild-type floral phenotype. In total, 16 mutant alleles were recovered which fell into three distinct classes. The first class of nine mutations were mapped to a gene, CHRO-MOMETHYLASE 3 (CMT3), which encodes a putative DNA methyltransferase with a chromodomain [11]. CMT3 seems restricted to the plant kingdom and cmt3 mutations affect the genomic methylation pattern in a very specific way. At all loci tested in the cmt3 mutant, CpG methylation was found to be wild-type, but CpXpG methylation was severely reduced. From these data it can be concluded that silencing of the clark kent epiallele mainly depends on CpXpG methylation.
are downstream of DNA methylation, as components of the DNA methylation machinery, such as the methyl-CpG binding protein MeCP2 [7] and the DNA methyltransferase Dnmt1 [8] , were shown to recruit histone deacetylases. But an important recent study [9] in the fungus Neurospora crassa showed that mutations in the gene decrease in DNA methylation (dim5), which encodes what looks likely to be a methyltransferase specific for histone H3 lysine 9, result in almost complete loss of cytosine methylation [9] . These data provided the first evidence that histone methylation can trigger DNA methylation, although it remained unresolved how histone H3 methylation could recruit a DNA methyltransferase.
It is precisely this question which is addressed by the new work of Jackson et al. [1] on SUPERMAN and clark kent. Arabidopsis plants homozygous for the clark kent allele show severe defects in floral architecture, notably an increase in the number of reproductive organs, stamens and carpels. This phenotype correlates with severely reduced expression of the floral development gene SUPERMAN, which is converted into the inactive 'epiallele' clark kent by cytosine methylation, both symmetrically at CpGs and CpXpGs and also at non-symmetrical sites [10] .
To investigate the molecular mechanism for this epigenetic transition, Jacobsen and colleagues [1, 11] performed EMS mutagenesis in a non-revertible, clk-st background, screening for progeny with a wild-type floral phenotype. In total, 16 mutant alleles were recovered which fell into three distinct classes. The first class of nine mutations were mapped to a gene, CHRO-MOMETHYLASE 3 (CMT3), which encodes a putative DNA methyltransferase with a chromodomain [11] . CMT3 seems restricted to the plant kingdom and cmt3 mutations affect the genomic methylation pattern in a very specific way. At all loci tested in the cmt3 mutant, CpG methylation was found to be wild-type, but CpXpG methylation was severely reduced. From these data it can be concluded that silencing of the clark kent epiallele mainly depends on CpXpG methylation.
The second class of three alleles were mapped to a gene dubbed KRYPTONITE (KYP), which encodes a protein with a SET domain, a hallmark motif of histone methyltransferases [6, 12] . Indeed, recombinant KYP protein was found to have methyltransferase activity specific for histone 3 lysine 9 [1] . Examination of the DNA methylation profile in a kyp mutant background revealed a defect in CpXpG methylation, remarkably similar to what has been observed in cmt3 mutants [1] . These data indicate that KYP-mediated histone H3 methylation can direct CpXpG methylation by CMT3, but how does it recruit CMT3?
The most direct model would suggest that CMT3 binds to the histone H3 lysine 9-methylated termini via its chromodomain. In vitro binding data, however, indicated that CMT3 does not interact significantly with H3 tails, methylated or not. Similarly, Suv39h histone methyltransferases were found to associate non-specifically with either unmodified or methylated histone tails, despite having chromodomains [13] . Selective recruitment of Suv39h histone methyltransferases requires interaction with the adaptor molecule HP1, which mediates binding to methylated histone tails [13] [14] [15] . Targeting of CMT3 seems to use the same principle, as the Arabidopsis HP1 homologue LIKE HETEROCHROMATIN PROTEIN 1 (LHP1) was shown to bind with increased affinity to H3 lysine 9 methylated tails, and to be able to interact with CMT3 [1] .
The model suggested by these data (Figure 1 ) is that KYP mediates histone H3 lysine 9 methylation in the vicinity of the SUPERMAN locus, creating a binding platform for LHP1. CMT3 is then recruited by LHP1 and transforms SUPERMAN into clark kent by catalysing cytosine methylation at CpXpG sites. Thus, SUPERMAN is forced into wearing a 'double disguise', in which both histone and DNA methylation cloak his 'supernatural' powers.
This mechanism implies that HP1 has a conserved role as an adaptor molecule that reads the histone H3 lysine 9 methylation mark. But it also raises important questions about the target specificity of other chromodomains. Two recent papers [16, 17] present the structure of the HP1 chromodomain in a complex with an H3 lysine 9 methylated peptide. The HP1 chromodomain structure, as described before [18] , consists of a three-stranded β β sheet folded against a carboxy-terminal α α helix. The H3 peptide inserts into a predicted groove in the HP1 structure, building a β β sheet by interaction with the flexible amino terminus of the chromodomain (Figure 2A) .
Binding of the H3 peptide induces a shift in the HP1 structure, resulting in the formation of a cage which depends on three aromatic side chains interacting with the methyl group on lysine 9 ( Figure 2B ). The complex structure reveals other important residues involved in recognizing the amino-acid sequence surrounding methylated lysine 9. Together, the data allow predictions about which chromodomains may or may not be able to bind to methylated lysine. But whereas CMT3, Suv39h and LHP1 all fulfill the requirements to be methyl-lysine binders ( Figure 2C ), only LHP1 displays enhanced affinity towards an H3 lysine 9 methylated peptide. By contrast, the related chromodomains of the MOF and MSL proteins, components of the Drosophila dosage-compensation complex, lack the conserved residues required to bind methylated lysine 9, and have been shown to associate with RNA [19] . There must be further determinants of chromodomain binding specificity that we do not yet know about.
Will there be a sequel to the timeless SUPERMAN story, and how is KYP targeted to the SUPERMAN locus? During development, there are likely to be fluctuations in the SUPERMAN expression level. As low transcriptional activity correlates with histone underacetylation, transcription-driven transitions in the histone modification pattern of the SUPERMAN chromatin region might modulate substrate specificity for the KYP histone methyltransferase, similar to what has been proposed for 'targeting' of the Suv39h histone methyltransferases [6] . Alternatively, we cannot exclude the action of an unknown factor, and in this respect the additional four alleles -the class 3 mutants -derived from the above mentioned EMS screen might hold some surprises.
Finally, when we leave the world of fungi and plants, we should ask what can be learned of relevance for mammalian systems? Although mammals apparently lack homologs of CMT3, and their DNA methylation is generally more complex (particularly for de novo DNA methylation), it seems almost certain that a similar functional link between histone and DNA methylation will soon be established. Thus, mammalian 'SUPERMEN', or related heroes, may also change their dress codes, which are again likely to include several layers of methylated accessories. 
